We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 05, 2018

Significant Differences in Progression Risk Between Patients With IgM MGUS and Non-IgM MGUS

The New England Journal of Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Long-Term Follow-Up of Monoclonal Gammopathy of Undetermined Significance
N. Engl. J. Med 2018 Jan 18;378(3)241-249, RA Kyle, DR Larson, TM Therneau, A Dispenzieri, S Kumar, JR Cerhan, SV Rajkumar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading